See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Feb. 11, 2004

Depression (Major/Severe) Lung Cancer Breast Cancer

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Depression (Major/Severe)

A clinical research study to test a TMS device to evaluate its safety and ability to improve mood in patients with major depression. Volunteers ages 18 - 70 who have been diagnosed with major depressive disorder (MDD) may be eligible. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat97.html.

-----

Lung Cancer

A clinical research study to assess the antitumor activity of CI-1033 in patients with progressive or recurrent, locally advanced (Stage IIIb) or metastatic (Stage IV) non-small cell lung cancer. Volunteers who are least 18 years old and have a histologically or cytologically documented diagnosis of non-small cell lung cancer (NSCLC) may be eligible. Research sites located throughout the world.

More Information

Please see http://www.centerwatch.com/patient/studies/cat34.html.

-----

Breast Cancer

A phase II study of CI-1033 in treating patients with metastatic (stage IV) breast cancer. Patients with histologically confirmed metastatic (Stage IV) breast cancer and who have received no more than two prior cytotoxic chemotherapy regimens may be eligible. Research sites located throughout the world.

More Information

Please see http://www.centerwatch.com/patient/studies/cat29.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined